These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
260 related articles for article (PubMed ID: 27108266)
21. DTS-108, a novel peptidic prodrug of SN38: in vivo efficacy and toxicokinetic studies. Meyer-Losic F; Nicolazzi C; Quinonero J; Ribes F; Michel M; Dubois V; de Coupade C; Boukaissi M; Chéné AS; Tranchant I; Arranz V; Zoubaa I; Fruchart JS; Ravel D; Kearsey J Clin Cancer Res; 2008 Apr; 14(7):2145-53. PubMed ID: 18381956 [TBL] [Abstract][Full Text] [Related]
22. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies. Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667 [TBL] [Abstract][Full Text] [Related]
23. Design and statistical modeling of mannose-decorated dapsone-containing nanoparticles as a strategy of targeting intestinal M-cells. Vieira AC; Chaves LL; Pinheiro M; Ferreira D; Sarmento B; Reis S Int J Nanomedicine; 2016; 11():2601-17. PubMed ID: 27354792 [TBL] [Abstract][Full Text] [Related]
24. Novel disulfide bond bridged 7-ethyl-10-hydroxyl camptothecin-undecanoic acid conjugate/human serum albumin nanoparticles for breast cancer therapy. Zhang Y; Wang J; Liu C; Xing H; Jiang Y; Li X J Mater Chem B; 2023 Mar; 11(11):2478-2489. PubMed ID: 36843543 [TBL] [Abstract][Full Text] [Related]
25. Design, characterization and in vitro evaluation of linalool-loaded solid lipid nanoparticles as potent tool in cancer therapy. Rodenak-Kladniew B; Islan GA; de Bravo MG; Durán N; Castro GR Colloids Surf B Biointerfaces; 2017 Jun; 154():123-132. PubMed ID: 28334689 [TBL] [Abstract][Full Text] [Related]
26. Single protein encapsulated SN38 for tumor-targeting treatment. Yu C; Huang F; Wang K; Liu M; Chow WA; Ling X; Li F; Causey JL; Huang X; Cook-Wiens G; Cui X J Transl Med; 2023 Dec; 21(1):897. PubMed ID: 38072965 [TBL] [Abstract][Full Text] [Related]
27. Development and characterization of a novel lipid nanocapsule formulation of Sn38 for oral administration. Roger E; Lagarce F; Benoit JP Eur J Pharm Biopharm; 2011 Sep; 79(1):181-8. PubMed ID: 21303693 [TBL] [Abstract][Full Text] [Related]
28. NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer. Adkins CE; Nounou MI; Hye T; Mohammad AS; Terrell-Hall T; Mohan NK; Eldon MA; Hoch U; Lockman PR BMC Cancer; 2015 Oct; 15():685. PubMed ID: 26463521 [TBL] [Abstract][Full Text] [Related]
30. Hyaluronic acid decorated pluronic P85 solid lipid nanoparticles as a potential carrier to overcome multidrug resistance in cervical and breast cancer. Wang F; Li L; Liu B; Chen Z; Li C Biomed Pharmacother; 2017 Feb; 86():595-604. PubMed ID: 28027535 [TBL] [Abstract][Full Text] [Related]
32. Enhancement in antifungal activity of eugenol in immunosuppressed rats through lipid nanocarriers. Garg A; Singh S Colloids Surf B Biointerfaces; 2011 Oct; 87(2):280-8. PubMed ID: 21689909 [TBL] [Abstract][Full Text] [Related]
33. Complete regression of xenograft tumors using biodegradable mPEG-PLA-SN38 block copolymer micelles. Lu L; Zheng Y; Weng S; Zhu W; Chen J; Zhang X; Lee RJ; Yu B; Jia H; Qin L Colloids Surf B Biointerfaces; 2016 Jun; 142():417-423. PubMed ID: 26994941 [TBL] [Abstract][Full Text] [Related]
34. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38. Bala V; Rao S; Boyd BJ; Prestidge CA J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356 [TBL] [Abstract][Full Text] [Related]
35. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery. Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777 [TBL] [Abstract][Full Text] [Related]
36. Preparation, characterization, and optimization of auraptene-loaded solid lipid nanoparticles as a natural anti-inflammatory agent: In vivo and in vitro evaluations. Daneshmand S; Jaafari MR; Movaffagh J; Malaekeh-Nikouei B; Iranshahi M; Seyedian Moghaddam A; Tayarani Najaran Z; Golmohammadzadeh S Colloids Surf B Biointerfaces; 2018 Apr; 164():332-339. PubMed ID: 29413613 [TBL] [Abstract][Full Text] [Related]
37. Human serum albumin conjugates of 7-ethyl-10-hydroxycamptothecin (SN38) for cancer treatment. Sepehri N; Rouhani H; Ghanbarpour AR; Gharghabi M; Tavassolian F; Amini M; Ostad SN; Ghahremani MH; Dinarvand R Biomed Res Int; 2014; 2014():963507. PubMed ID: 24895635 [TBL] [Abstract][Full Text] [Related]
38. Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Lee MK; Lim SJ; Kim CK Biomaterials; 2007 Apr; 28(12):2137-46. PubMed ID: 17257668 [TBL] [Abstract][Full Text] [Related]
39. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of SN-38 nanocrystals with different particle sizes. Chen M; Li W; Zhang X; Dong Y; Hua Y; Zhang H; Gao J; Zhao L; Li Y; Zheng A Int J Nanomedicine; 2017; 12():5487-5500. PubMed ID: 28814865 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]